Výsledky vyhledávání - Nicolas Signolle
- Zobrazuji výsledky 1 - 8 z 8
-
1
TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy Autor Pauline Hamon, Marine Gerbé de Thoré, Marion Classe, Nicolas Signolle, Winchygn Liu, Olivia Bawa, Lydia Meziani, Céline Clémenson, Fabien Milliat, Éric Deutsch, Michele Mondini
Vydáno 2022Artigo -
2
LBA1 Unraveling the mechanism of action and resistance to trastuzumab deruxtecan (T-DXd): Biomarker analyses from patients from DAISY trial Autor M.F. Mosele, Amélie Lusque, Véronique Dièras, Élise Deluche, Agnès Ducoulombier, Barbara Pistilli, T. Bachelot, F. Viret, Christelle Lévy, Nicolas Signolle, D. Tran, Ingrid Garberis, Loic Le-Bescond, Alicia Tran Dien, Nathalie Droin, Michihiko Kobayashi, Tomoya Kakegawa, Martha Jimenez, Magali Lacroix‐Triki, Fabrice André
Vydáno 2022Artigo -
3
CD103+CD8+ TRM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17 Autor Stéphanie Corgnac, Ines Malenica, Laura Mezquita, Édouard Auclin, Elodie Voilin, Jamila Kacher, Heloise M. Halse, Laetitia Grynszpan, Nicolas Signolle, Thibault Dayris, Marine Leclerc, Nathalie Droin, Vincent de Montpréville, Olaf Mercier, Pierre Validire, Jean–Yves Scoazec, Christophe Massard, Salem Chouaı̈b, David Planchard, Julien Adam, Benjamin Besse, Fathia Mami‐Chouaib
Vydáno 2020Artigo -
4
BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer Autor Mathieu Rouanne, Julien Adam, C. Radulescu, Diane Letourneur, Delphine Bredel, Séverine Mouraud, Anne‐Gaëlle Goubet, Marion Leduc, Noah Chen, Tuan Zea Tan, Nicolas Signolle, Amélie Bigorgne, Michaël Dussiot, Lambros Tselikas, Sandrine Susini, François‐Xavier Danlos, Anna K. Schneider, Roman M. Chabanon, Sophie Vacher, Ivan Bièche, Thierry Lebrét, Yves Allory, Jean‐Charles Soria, Nicholas Arpaia, Guido Kroemer, Oliver Kepp, Jean Paul Thiery, Laurence Zitvogel, Aurélien Marabelle
Vydáno 2022Artigo -
5
Single-cell multiomics profiling reveals heterogeneous transcriptional programs and microenvironment in DSRCTs Autor Clémence Hénon, Julien Vibert, Thomas Eychenne, Nadège Gruel, Léo Colmet-Daage, Carine Ngo, Marlène Garrido, Nicolas Dorvault, Maria Eugénia Marques Da Costa, Virginie Marty, Nicolas Signolle, Antonin Marchais, Noé Herbel, Asuka Kawai-Kawachi, Madison M. Lenormand, Clémence Astier, Roman M. Chabanon, Benjamin Verret, Rastislav Bahleda, Axel Le Cesne, Fatima Mechta‐Grigoriou, Matthieu Faron, Charles Honoré, Olivier Delattre, Joshua J. Waterfall, Sarah Watson, Sophie Postel‐Vinay
Vydáno 2024Artigo -
6
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial Autor Fernanda Mosele, Élise Deluche, Amélie Lusque, Loïc Le Bescond, Thomas Filleron, Yoann Pradat, Agnès Ducoulombier, Barbara Pistilli, Thomas Bachelot, F. Viret, Christelle Lévy, Nicolas Signolle, Alexia Alfaro, Diep Thi Ngoc Tran, Ingrid Garberis, Hugues Talbot, Stergios Christodoulidis, Maria Vakalopoulou, Nathalie Droin, Aurelie Stourm, Maki Kobayashi, Tomoya Kakegawa, Ludovic Lacroix, Patrick Saulnier, Bastien Job, Marc Deloger, Marta Jimenez, Céline Mahier - Aït Oukhatar, Vianney Baris, Pierre Laplante, Patricia Kannouche, Virginie Marty, Magali Lacroix‐Triki, Véronique Dièras, Fabrice André
Vydáno 2023Artigo -
7
Safety, recommended dose, efficacy and immune correlates for nintedanib in combination with pembrolizumab in patients with advanced cancers Autor Capucine Baldini, François‐Xavier Danlos, Andreea Varga, Matthieu Texier, Heloise M. Halse, Séverine Mouraud, Lydie Cassard, Stéphane Champiat, Nicolas Signolle, Perrine Vuagnat, Patricia Martín-Romano, Jean‐Marie Michot, Rastislav Bahleda, Anas Gazzah, Lisa Boselli, Delphine Bredel, Jonathan Grivel, Chifaou Mohamed-Djalim, Guillaume Escriou, Laetitia Grynszpan, Amélie Bigorgne, Saloomeh Rafie, Alae Abbassi, Vincent Ribrag, Sophie Postel‐Vinay, Antoine Hollebecque, Sandrine Susini, Siham Farhane, Ludovic Lacroix, Aurélien Parpaleix, Salim Laghouati, Laurence Zitvogel, Julien Adam, Nathalie Chaput, Jean‐Charles Soria, Christophe Massard, Aurélien Marabelle
Vydáno 2022Artigo -
8
<i>Escherichia coli</i>–Specific CXCL13-Producing TFH Are Associated with Clinical Efficacy of Neoadjuvant PD-1 Blockade against Muscle-Invasive Bladder Cancer Autor Anne‐Gaëlle Goubet, Leonardo Lordello, Carolina Alves Costa Silva, Isabelle Peguillet, Marianne Gazzano, Maxime Descartes Mbogning Fonkou, Cassandra Thélémaque, C. Lebâcle, Constance Thibault, François Audenet, G. Pignot, Gwénaëlle Gravis, Carole Hélissey, Luca Campedel, Morgan Rouprêt, Évanguelos Xylinas, I. Ouzaïd, Agathe Dubuisson, Marine Mazzenga, Caroline Flament, Pierre Ly, Virginie Marty, Nicolas Signolle, Allan Sauvat, Thomas Sbarrato, Mounia Filahi, Caroline Davin, Gabriel Haddad, Jacques Bou Khalil, Camille Blériot, François‐Xavier Danlos, Garett Dunsmore, Kevin Mulder, Aymeric Silvin, Thibault Raoult, Baptiste Archambaud, Shaima Belhechmi, Ivo G. Boneca, Nadège Cayet, Maryse Moya‐Nilges, Adeline Mallet, Romain Daillère, Étienne Rouleau, C. Radulescu, Yves Allory, Jacques Fieschi, Mathieu Rouanne, Florent Ginhoux, Gwénaël Le Teuff, Lisa Derosa, Aurélien Marabelle, Jeroen van Dorp, Nick van Dijk, Michiel S. van der Heijden, Benjamin Besse, Fabrice André, Miriam Mérad, Guido Kroemer, Jean–Yves Scoazec, Laurence Zitvogel, Yohann Loriot
Vydáno 2022Artigo
Vyhledávací nástroje:
Související témata
Medicine
Internal medicine
Cancer
Immunotherapy
Biochemistry
Biology
Cancer research
Immunology
Chemistry
Immune system
Oncology
Antibody
Bladder cancer
Breast cancer
Cytotoxic T cell
Immunohistochemistry
In vitro
Trastuzumab
Adverse effect
Antigen
Biomarker
Blockade
CD8
CXCL13
Cancer immunotherapy
Cell biology
Chemokine
Chemokine receptor
Clinical endpoint
Clinical trial